Head of HE

Lead strategic discussions with business unit, product, access, government affairs and medical leaders to define HE priorities, evidence plans, studies and therapy economic tools aligned with portfolio and access objectives. Provide leadership and subject matter expertise in Health Technology Assessment, reimbursement policy, real-world evidence and health economic evaluation to guide strategic decision making. Oversee the design and development of high-quality HE models, value tools and evidence-generation initiatives based on representative clinical and pharmacoeconomic studies, local data needs and identified evidence gaps. Ensure economic evaluations, evidence outputs and stakeholder materials meet high standards of quality, integrity, compliance and timely delivery. Champion the use of credible official sources, local evidence and external insights to generate compelling analyses, presentations and value narratives for internal and external stakeholders. Partner with global teams as the China HE voice to ensure global strategies reflect local market nuances and, where required, lead local evidence generation to address China-specific access and payer requirements. Provide leadership support for Government Affairs and Market Access engagement by shaping evidence-based narratives, preparing for key stakeholder discussions and ensuring follow-up actions are connected to broader strategic objectives. Build and lead the HE function with clear priorities, strong governance, effective cross-functional collaboration and a culture of accountability, strategic thinking and continuous capability development. Main Activities and Responsibilities: Serve as the strategic HE lead and trusted advisor to Access and Government Affairs, ensuring HE priorities are embedded in market access planning and stakeholder engagement. Lead, supervise and coordinate the development and implementation of pharmacoeconomic analyses, ensuring appropriate prioritization, resource allocation and cross-functional input. Guide the generation, implementation and adaptation of local or global tools that demonstrate the economic and societal value of the acute and chronic portfolios in China. Lead the preparation of value dossiers and evidence packages for inclusion and access processes, partnering closely with Medical Affairs, Market Access, Government Affairs and global teams. Shape and support tactical actions that deepen relationships with government payers and other economic stakeholders, ensuring engagements are evidence-based and aligned with long-term access priorities. Lead by example in fostering a culture of compliance, ethical business conduct and responsible evidence communication across the organization. Ensure effective implementation of Vantive’s code of conduct, policies and procedures, including but not limited to the Global Interactions Policy and Third-Party Policy, while supporting employee onboarding, training and ongoing compliance awareness.

职位描述

职位要求